Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OT1Z
|
||||
Former ID |
DNC011314
|
||||
Drug Name |
NSC-356820
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C21H18N4O
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C=CC2=CC(=NNC3=CC=C(C=C3)C(=N)N)C(=O)C=C2.<br />Cl
|
||||
InChI |
1S/C21H18N4O.ClH/c22-21(23)17-9-11-18(12-10-17)24-25-19-14-16(8-13-20(19)26)7-6-15-4-2-1-3-5-15;/h1-14,24H,(H3,22,23);1H/b7-6+,25-19-;
|
||||
InChIKey |
FNEFXNWITWHMSQ-NGCRPXRTSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [1] | |
References | |||||
REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.